We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » White House Signals Support of Obscure Law to Lower Prices on Taxpayer-Funded Drugs
White House Signals Support of Obscure Law to Lower Prices on Taxpayer-Funded Drugs
Angering drugmakers, the Biden Administration announced Thursday that it’s supporting a previously unused, obscure and controversial regulatory authority called “march-in” rights to achieve lower prices on taxpayer-funded drugs deemed too expensive for consumers.